A common human skin tumour is caused by activating mutations in β- catenin

Nature Genetics

Volumn 21, Issue 4, 1999, Pages 410-413

  Chan, Edward F ^a   Gat, Uri ^a   McNiff, Jennifer M ^b   Fuchs, Elaine ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL PROLIFERATION; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; HUMAN TISSUE; MORPHOGENESIS; MULTIGENE FAMILY; PILOMATRIXOMA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; SKIN TUMOR; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; BETA CATENIN; CYTOSKELETAL PROTEINS; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA-BINDING PROTEINS; GENE FREQUENCY; HAIR DISEASES; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MOLECULAR SEQUENCE DATA; MUTATION; PILOMATRIXOMA; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; SKIN NEOPLASMS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

EID: 0032953231     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/7747     Document Type: Article

References (30)

1. Miller, J.R. & Moon, R.T. Signal transduction through β-catenin and specification of cell fate during embryogenesis. Genes Dev. 10, 2527-2539 (1996).
2. Willert, K. & Nusse, R. β-catenin: a key mediator of Wnt signaling. Curr. Opin. Genet. Dev. 8, 95-102 (1998).
3. Barth, A.I., Nathke, I.S. & Nelson, W.J. Cadherins, catenins and APC protein: interplay between cytoskeletal complexes and signaling pathways. Curr. Opin. Cell Biol. 9, 683-690 (1997).
4. Behrens, J. et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382, 638-642 (1996).
5. Bienz, M. TCF: transcriptional activator or repressor? Curr. Opin. Cell Biol. 10, 366-372 (1998).
6. He, T.C. et al. Identification of c-MYC as a target of the APC pathway. Science 281, 1509-1512 (1998).
7. Kinzler, K.W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
8. Rubinfeld, B. et al. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792 (1997).
9. Morin, P.J. et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275, 1787-1790 (1997).
10. Palacios, J. & Gamallo, C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res. 58, 1344-1347 (1998).
11. Muller, O., Nimmrich, I., Finke, U., Friedl, W. & Hoffmann, I. A β-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β-catenin germline mutations in FAP patients. Genes Chromosomes Cancer 22, 37-41 (1998).
12. Miyoshi, Y. et al. Activation of the β-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58, 2524-2527 (1998).
13. Zurawel, R.H., Chiappa, S.A., Allen, C. & Raffel, C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res. 58, 896-899 (1998).
14. Voeller, H.J., Truica, C.I. & Gelmann, E.P. β-catenin mutations in human prostate cancer. Cancer Res. 58, 2520-2523 (1998).
15. Fukuchi, T. et al. β-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 58, 3526-3528 (1998).
16. Sparks, A.B., Morin, P.J., Vogelstein, B. & Kinzler, K.W. Mutational analysts of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58, 1130-1134 (1998).
17. de La Coste, A. et al. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl Acad. Sci. USA 95, 8847-8851 (1998).
18. Gat, U., DasGupta, R., Degenstein, L. & Fuchs, E. De novo hair follicle morphogenesis and hair tumors in mice expressing a truncated β-catenin in skin. Cell 95, 605-614 (1998).
19. Zhou, P., Byrne, C., Jacobs, J. & Fuchs, E. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev. 9, 570-583 (1995).
20. van Genderen, C., Okamura, R.M., Farinas, I., Quo, R.-G. & Parslow, T.G. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev. 8, 2691-2703 (1994).
21. Munemitsu, S., Albert, I., Rubinfeld, B. & Polakis, P. Deletion of an amino-terminal sequence stabilizes β-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol. Cell. Biol. 16, 4088-4094 (1996).
22. Aberle, H., Bauer, A., Stappert, J., Kispert, A. & Kemler, R. β-catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16, 3797-3805 (1997).
23. Cadigan, K.M. & Nusse, R. Wnt signaling: a common theme in animal development. Genes Dev. 11, 3286-3305 (1997)
24. Peifer, M., Pai, L.M. & Casey, M. Phosphorylation of the Drosophila adherens junction protein Armadillo: roles for wingless signal and zeste-white 3 kinase. Dev. Biol. 166, 543-556 (1994).
25. Yost, C. et al. The axis-inducing activity, stability, and subcellular distribution of β-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev. 10, 1443-1454 (1996).
26. Orford, K., Crockett, C., Jensen, J.P., Weissman, A.M. & Byers, S.W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem. 272, 24735-24738 (1997).
27. Chen, Z.J., Parent, L. & Maniatis, T. Site-specific phosphorylation of IκBα by a novel ubiquitination-dependent protein kinase activity. Cell 84, 853-862 (1996).
28. 2-terminal truncated β-catenin on mouse intestinal epithelial homeostasis. J. Cell Biol. 141, 765-777 (1998).
29. Foulkes, W.D. A tale of four syndromes: familial adenomatous polyposis, Gardner syndrome, attenuated APC and Turcot syndrome. QJM 88, 853-863 (1995).
30. Pujol, R.M., Casanova, J.M., Egido, R., Pujol, J. & de Moragas, J.M. Multiple familial pilomatricomas: a cutaneous marker for Gardner's syndrome? Pediatr. Dermatol. 12, 331-335 (1995).